AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kunz, A.
Right arrow Articles by Gahn, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kunz, A.
Right arrow Articles by Gahn, G.

BRAIN

Echo-Enhanced Transcranial Color-Coded Duplex Sonography in the Diagnosis of Cerebrovascular Events: A Validation Study

A. Kunza, G. Hahna, D. Muchab, A. Müllerb, K.M. Barrettc, R. von Kummerb and G. Gahna

a Department of Neurology, University of Technology Dresden, Dresden, Germany
b Department of Neuroradiology, University of Technology Dresden, Dresden, Germany
c Department of Neurology, Mayo Graduate School of Medicine, Mayo Clinic, Jacksonville, Fla

Please address correspondence to: Georg Gahn, MD, Department of Neurology, University of Technology Dresden, Fetscher Str 74, 01307 Dresden, Germany; e-mail: gahn{at}rcs.urz.tu-dresden.de

BACKGROUND AND PURPOSE: Transcranial color-coded duplex sonography (TCCD) is a diagnostic technique for evaluation of intracranial arteries in patients with acute stroke. Echo-enhancing contrast agents (EEAs) are necessary to visualize intracranial vessels in up to 30% of patients because of limited acoustic bone windows. In this study, we assessed the diagnostic efficacy of echo-enhanced TCCD (eTCCD) in correlation with the gold standard, digital subtraction angiography (DSA).

METHODS: We prospectively evaluated all patients with eTCCD who subsequently underwent DSA for evaluation of cerebrovascular symptoms over a 24-month period. We administered Levovist as an EEA. Two blinded reviewers analyzed all eTCCD findings and correlated them with DSA.

RESULTS: We included 132 consecutive patients (40 women, 92 men; mean age, 58 ± 14 years) with 164 datasets: 24/164 had normal findings, 98/164 had abnormalities of extracranial carotid arteries, 32/164 had abnormalities of intracranial arteries, and 21/164 had abnormalities in vertebrobasilar circulation as determined by DSA. For eTCCD, we found a sensitivity of 82% (95% confidence interval [CI]: 75%–90%), a specificity of 98% (95% CI: 90%–100%), a positive predictive value of 99% (95% CI: 94%–100%), and a negative predictive value of 75% (95% CI: 64%–85%); 7/164 (4%) examinations were inconclusive because of insufficient bone windows. The interobserver agreement was almost perfect ({kappa} value, 0.92; 95% CI: 0.87–0.97).

CONCLUSION: eTCCD provides high diagnostic validity for the status of the major intracranial arteries. In particular, a normal vessel status reliably assessed by an experienced sonographer could supersede further imaging procedures. In patients with acute ischemic stroke not eligible for established angiographic techniques, eTCCD may be useful as an alternative imaging technique.